Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): Grant/Award of 275,000 SEPN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Septerna, Inc. (SEPN) | Grant/Award | 275,000 | n/a |
| Jan 13, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 17,000 | n/a |
| Jun 6, 2025 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 27,000 | n/a |
| Jan 16, 2025 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 44,000 | n/a |
| Jun 8, 2024 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 13,500 | n/a |
| Feb 15, 2024 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 54,000 | n/a |